New scan could spare thyroid cancer patients from ineffective treatment
NCT ID NCT03647358
Summary
This study is testing a new type of PET scan that uses a special form of iodine (iodine-124) to better measure how much radioactive iodine is taken up by thyroid cancer that has spread. The goal is to see if this scan can more accurately predict which patients will benefit from standard radioactive iodine therapy. If the scan shows low uptake, doctors may recommend a different treatment approach instead.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact Phone: •••-•••-••••
Contact
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.